Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem
Angela Kunzler(University of Freiburg), Joerg J Meerpohl(University Medical Center Freiburg), Claire Iannizzi(University of Cologne), Daniela Zöller(University of Freiburg), Andy Maun(University Medical Center Freiburg), Christine Schmucker(University of Freiburg), Harald Binder(Zimmer Biomet (Netherlands)), Anke Steckelberg(Martin Luther University Halle-Wittenberg), Claudia Spies(Apple (Israel)), Eva Rehfuess(Zimmer Biomet (Netherlands)), Maximilian Markus Wunderlich(Charité - Universitätsmedizin Berlin), Falk Fichtner(University Hospital Leipzig), Hajo Grundmann(University of Freiburg), Carina Benstoem(RWTH Aachen University), Maria Popp(Universitätsklinikum Würzburg), Monika Nothacker(Association of the Scientific Medical Societies), Martin Boeker(TUM Klinikum), Christoph Schmaderer(TUM Klinikum), Gregor Lichtner(Universitätsmedizin Greifswald), Vanessa Piechotta(Robert Koch Institute), Hartmut Hengel(University of Freiburg), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Sebastian Voigt-Radloff(University Medical Center Freiburg), Christopher Holzmann‐Littig(TUM Klinikum), Stephanie Weibel(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Peter Kranke(Universitätsklinikum Würzburg), Felix Balzer(Humboldt-Universität zu Berlin), Nico T. Mutters(University Hospital Bonn), Maria‐Inti Metzendorf(Heinrich Heine University Düsseldorf), Sven Laudi(Leipzig University), Lukas Schwingshackl(University of Freiburg), Georg Rüschemeyer(Cochrane), Winfried V. Kern(University Medical Center Freiburg), Nina Kreuzberger(University of Cologne), Falk von Dincklage(Universitätsmedizin Greifswald), Daniel Strech(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Miriam Stegemann(LRS Institute of Tuberculosis and Respiratory Diseases), Jacob Burns(Zimmer Biomet (Netherlands)), Onnen Moerer(Universitätsmedizin Göttingen), Jonas Jabs(University Hospital Bonn), Nicole Skoetz(Medical University of Vienna), I. Kopp(Philipps University of Marburg), Klaus Lieb(Johannes Gutenberg University Mainz), Lisa M. Pfadenhauer(Ludwig-Maximilians-Universität München), Anika Müller(Humboldt-Universität zu Berlin), Martin Golinski(University of Göttingen)
Cited by 6
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k
GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
|Journal of Clinical Epidemiology|2013|1.3k